Patents by Inventor Michael C. Van Zandt

Michael C. Van Zandt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted phenoxyacetic acids
    Patent number: 6420426
    Abstract: Disclosed are substituted phenoxyacetic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds, alone or in combination with other therapeutic agents, and methods of treatment employing the compounds and pharmaceutical compositions, as well as methods for their synthesis.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: July 16, 2002
    Assignee: The Institute for Pharmaceutical Discovery LLC
    Inventor: Michael C. Van Zandt
  • Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
    Publication number: 20010041722
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds. Further, disclosed are combinations of an angiotensin converting enzyme inhibitor and a substituted indole acetic acid.
    Type: Application
    Filed: February 28, 2001
    Publication date: November 15, 2001
    Inventors: Janet Sredy, Michael C. Van Zandt
  • Substituted indolealkanoic acids
    Patent number: 6214991
    Abstract: Disclosed are substituted indolealkanoic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their synthesis.
    Type: Grant
    Filed: March 31, 1999
    Date of Patent: April 10, 2001
    Assignee: The Institute for Pharmaceutical Discovery, Inc.
    Inventors: Michael Lee Jones, David Gunn, John Howard Jones, Michael C. Van Zandt